Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells

Apatinib, a new-generation oral tyrosine kinase inhibitor targeting the vascular endothelial growth factor receptor 2 (VEGFR2) signaling pathway, shows favorable therapeutic effects in various malignant tumors. However, its effect on ovarian cancer has not yet been characterized. Here, we demonstrat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oxid Med Cell Longev
Egile Nagusiak: Sun, Xiaodan, Li, Ji, Li, Yizhuo, Wang, Shouhan, Li, Qingchang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7244982/
https://ncbi.nlm.nih.gov/pubmed/32509141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3145182
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak